Lessons Learned: New FDA Guidance On Meetings With Sponsors Adds Depth
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA's new iteration of its guidance on meetings with sponsors reflects lessons learned during the surge in meeting requests the agency has had in the nine years since FDA issued the original formal meetings final guidance in February 2000